Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Dosing time affects finasteride's effectiveness and safety in rats.

A type of collagen helps hair grow by boosting cell growth and activating a specific hair growth pathway.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Antibody treatments show promise for hair loss but need more research.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.

Estrogen therapy can reduce skin aging but has cancer risks.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.